Effect of metformin on diastolic heart failure in diabetic patient with ?diastolic heart failure

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N69

Enrollment

114

Registered

2018-02-20

Start date

2017-10-29

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melitus diabetes. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Intervention group: The first group of patients receiving metformin .The first one ?received 500 milligram of metformin in the first week and we added 500 milligram to the patient's di

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Not receiving metformin over the past 6 months HbA1C less than 8/5 ?Preserved EFor normal EF

Exclusion criteria

Exclusion criteria: Intolerance to metformin DKA GFR less than 30 systolic heart failure

Design outcomes

Primary

Measure	Time frame
Determine the degree of diastolic failure. Timepoint: Initially and 4 months after starting treatment. Method of measurement: Ecocardiography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza Alisaeedi

Arak University of Medical Sciences

Alisaeedi@arakmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026